PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

Biotechnology

Healthcare
$1.22 +3.91%

+$0.04 today

Market cap
$65.06M
Beta
1.36
P/E (TTM)
-0.8
EPS (TTM)
-$1.47
52W Low $0.96High $1.88

Volume 0.43M

Average 0.38M

PMVP Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How PMVP compares with its peers on the latest reported figures

PMVP Competitors Peer median
Operating Margin for PMVP and competitors
Company Period LTM level YoY 3-year change
VXRTVaxart, Inc.LTM Mar 202614.9% +135.5 pp+107098.3 pp
CBUSCibus, Inc.LTM Mar 2026-1375.7% +4108.7 pp+12394.5 pp
TCRXTScan Therapeutics, Inc.LTM Mar 2026-1408.7% +1751.1 pp-823.1 pp
ATYRaTyr Pharma, Inc.LTM Mar 2026-38573.7% —-40409.5 pp
PMVPPMV Pharmaceuticals, Inc.FY2025— ——
RLMDRelmada Therapeutics, Inc.FY2025— ——
IMUXImmunic, Inc.FY2025— ——
ACRVAcrivon Therapeutics, Inc. Common StockFY2025— ——
BMEABiomea Fusion, Inc.FY2025— ——
Peer median (excluding PMVP) -1392.2%+1751.1 pp+5785.7 pp

Competitors are the stored peer set for PMVP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue1.28M650K1.26M1.14M0
Gross Profit(1.28M)(650K)(1.26M)(1.14M)0
Gross Margin—————
Research & Development36.19M51.67M54.63M57.38M69.88M
Selling, General & Admin20.83M24.72M24.25M26.92M16.33M
Operating Expenses57.01M76.39M78.88M84.3M86.21M
Depreciation & Amortization1.28M650K1.26M1.14M133K
EBITDA(56.54M)(72.68M)(67.7M)(73.67M)(79.78M)
EBITDA Margin—————
Operating Income(58.29M)(77.04M)(80.13M)(85.45M)(86.21M)
Operating Margin—————
Interest Income449K3.63M11.17M10.66M6.34M
Interest Expense00000
Other Income / Expenses470K3.71M11.17M10.64M6.29M
Income Before Tax(57.82M)(73.33M)(68.96M)(74.81M)(79.91M)
Pre-Tax Margin—————
Income Tax Expense23K(9K)2K(16.1M)(2.17M)
Net Income(57.85M)(73.32M)(68.96M)(58.71M)(77.74M)
Net Margin—————
EPS (Basic)(1.28)(1.61)(1.44)(1.14)(1.48)
EPS (Diluted)(1.28)(1.61)(1.44)(1.14)(1.48)
Weighted Avg Shares45.14M45.59M48.01M51.58M52.54M
Weighted Avg Shares (Diluted)45.14M45.59M48.01M51.58M52.54M

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

Intrinsic Alpha fair value

Locked

Current Price

$1.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.